FDA approval is about to send this stock up fifty fold

12 April 2017

Why is Quest Management (Symbol: QSMG) guaranteed to jump 5,000% this month?

They have a cure for cancer.

This biotech is run by some of the most prolific scientists in America. Together, they have more than 400 years of experience in the field and have more diplomas than we can even imagine.

Cancer kills 1 out of 4 people in our country and we have all been affected by it either directly or indirectly.

Who doesn't know someone who's died from it?

The company's scientists are targeting cancer using stem cells. They are able to identify the bad cells and destroy them without radiating the entire body (like is common with chemo).

Apart from saving millions of lives, their treatment will surely become the No1 selling drug on earth.

The company has already made serious headway thanks to nearly two decades of research.

This cutting edge biotech company has completed animal trials successfully and just wrapped up FDA-approved human trials last week.

The next step is the public announcement of those results, which we hear through the grapevine have beat all expectations and will change the world of medicine forever.

The results will be announced this month, and once they are out the stock will jump to $25 a share overnight and will continue up to $50 or more quickly after.

"Quest"'s biotech arm could have a cancer cure that can be totally effective in killing tumors in more than 40% of patients worldwide available in hospitals throughout the globe by the end of the year.

Once that happens, we're talking about a $1000 a share stock.

We're literally coming in at the last mile, out of no where, and grabbing profits from their last 2 decades of hard work.

Consider buying QSMG right now while it's still at under 5 dollars and make sure to tell all your friends to do the same before the price explodes.

0 comments:

Posting Komentar

Tolong jangan Spam ya..
Malah kita semua yang rugi..

 
 
 
 
Copyright © 2009-2010 Iklan Baris Dofollow. All Rights Reserved.